Navigation Links
Questcor to Initiate Pilot Commercialization Effort In Pulmonology for Symptomatic Sarcoidosis
Date:7/11/2013

e products;
  • Our ability to continue to generate revenue from sales of Acthar to treat on-label indications associated with NS, MS, IS or rheumatology-related conditions, and our ability to develop other therapeutic uses for Acthar, including symptomatic sarcoidosis;
  • Research and development risks, including risks associated with Questcor's work in the area of NS and Lupus, and potential work in the area of symptomatic sarcoidosis;
  • The results of any pending or future litigation, investigations or claims, including with respect to the investigation by the United States Attorney's Office for the Eastern District of Pennsylvania regarding the Company's promotional practices and litigation brought by certain shareholders arising from the federal securities laws, currently pending in the United States District Court for the Central District of California;
  • Our ability to comply with federal and state regulations, including regulations relating to pharmaceutical sales and marketing practices;
  • An increase in the proportion of our Acthar unit sales comprised of Medicaid-eligible patients and government entities;
  • Our ability to estimate reserves required for Acthar used by government entities and Medicaid-eligible patients and the impact that unforeseen invoicing of historical Medicaid prescriptions may have upon our results;
  • Our ability to effectively manage our growth, including the expansion of our sales forces, and our reliance on key personnel; and
  • Other risks discussed in Questcor's annual report on Form 10-K for the year ended December 31, 2012 as filed with the Securities and Exchange Commission, or SEC, on February 27, 2013, and other documents filed with the SEC.
  • The risk factors and other information contained in these documents should be considered in evaluating Questcor's prospects and future f
    '/>"/>

    SOURCE Questcor Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Questcor Pharmaceuticals to Present at JMP Securities Healthcare Conference
    2. Questcor to Report Second Quarter Results on July 24, 2012
    3. Questcor Reports Second Quarter Financial Results
    4. Questcor Pharmaceuticals to Present at Investor Conferences in September
    5. Questcor and The Myositis Association Team Up To Support Research and Educational Initiatives in Polymyositis and Dermatomyositis
    6. Questcor Comments on Insurance Policy Bulletin
    7. Questcor to Conduct Conference Call to Discuss Reimbursement Process
    8. Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
    9. Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set for December 21, 2012
    10. Questcor Pharmaceuticals Appoints Michael Aldridge to the Position of Senior Vice President, Corporate Strategic Development
    11. Questcor to Report Fourth Quarter and Full Year 2012 Financial Results on February 26, 2013
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2015)... Sept. 2, 2015 About Chronic Lymphocytic Leukemia ... condition characterized by increased production of lymphocytes. It has ... then it can spread to other parts of the ... because of the slow buildup of the cancerous cells. ... to the spleen, liver, and lymph nodes. The course ...
    (Date:9/2/2015)... 2, 2015   Physicians Rx Pharmacy ("PRxP") ... joined the organization as President and Chief Executive Officer.  ... President and Chief Executive Officer for Soleo Health Specialty ... of Physicians Rx Pharmacy, be responsible for leading the ... extremely pleased to bring Gaston on as the President ...
    (Date:9/2/2015)... THOUSAND OAKS, Calif. , Sept. 2, 2015 ... announced the submission of a Marketing Authorization Application ... the centralized procedure for etelcalcetide (formerly AMG 416) ... adult patients with chronic kidney disease (CKD) on ... first calcimimetic agent that can be administered intravenously. ...
    Breaking Medicine Technology:Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 2Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 3Gaston L. Bernstein Named President and CEO of Physicians Rx Pharmacy 2Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 2Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 3Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 4Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 5Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 6Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 7
    ... 6, 2007 - Neurologix, Inc.,(OTCBB:NRGX), a biotechnology company ... the brain and central nervous system,announced today that ... Unterberg Towbin Emerging Growth Conference on Tuesday July,10, ... Oriental Hotel in New York., President and Chief ...
    ... 05, 2007 /PRNewswire/ -- Alfacell,Corporation today announced ... financial officer and corporate secretary, will,present an ... 8 a.m. EDT on Thursday, July 12, ... Opportunities Conference in New York. , The ...
    Cached Medicine Technology:Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging,Growth Opportunities Conference 2
    (Date:9/3/2015)... , ... September 03, 2015 , ... A scar is an unavoidable result of incision ... example of the body's ability to heal itself. The appearance of a scar is dependent ... individual's age, genes, and skin pigmentation. ”Many scars fade to near invisibility on their own ...
    (Date:9/3/2015)... ... September 03, 2015 , ... ... will be participating at the highly anticipated Mississippi Gulf Babypalooza on September 19, ... from all over, from Gulfport, Biloxi, and beyond. We will be discussing setting ...
    (Date:9/3/2015)... ... ... 220,800 new cases of prostate cancer are reported each year, along with 27,540 deaths attributed ... their lifetime. While only one man in 10,000 will typically get prostate cancer under age ... the American Cancer Society. , Prostate cancer is the second leading ...
    (Date:9/3/2015)... ... ... Doctor Kayode Sotonwa can be counted on time and time ... medicine keeps patients happy and healthy, something that is important to everyone. In fact, ... even more so in the fall, when holiday eating and seasonal illnesses are potential ...
    (Date:9/2/2015)... ... September 03, 2015 , ... Leah Binder, MA, MGA, president ... leaders in healthcare, will offer the keynote address at the upcoming meeting of ... in Palm Harbor, Florida, at the Innisbrook Resort and Golf Club. For an ...
    Breaking Medicine News(10 mins):Health News:Do I Have To Live With That Scar? 2Health News:Do I Have To Live With That Scar? 3Health News:Do I Have To Live With That Scar? 4Health News:State Farm Agent EJ Roberts to Help Expecting Mothers at the Mississippi Gulf Babypalooza 2Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 2Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 3Health News:Doctor Kayode Sotonwa Highlights Expert Tips for Staying in Shape This Fall 2Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 2Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 3
    ... health care, doctors are often pressed for time during ... a tool that allows doctors to view electronic information ... single computer screen. A new study shows that this ... enhances patient care. The diabetes dashboard provides information ...
    ... By Dennis Thompson HealthDay Reporter , FRIDAY, Nov. ... into her day-to-day meals didn,t stem from any aversion to them. ... that," said Stewart, 67, a Baltimore resident who said her love ... meal -- we were brought up that way -- so we ...
    ... press release is available in French . ... noses, sore throats and clammy skin are as seasonal as ... they insecure about their jobs? A new study ... Health Psychology , has found that presenteeism, i.e. attending work ...
    ... The New Jersey Health Information Technology Extension Center (NJ-HITEC) ... care providers member milestone in support of the healthcare ... Each member doctor has signed an agreement pledging ... of EHRs; to earn the federal incentive funds pursuant ...
    ... Nov. 17 (HealthDay News) -- For the first time in more ... new U.S. government report shows. Although the drop reported by ... percent in 2009 to 32.8 percent in 2010, experts say it ... leveled off. "But with only one data point, we have ...
    ... tumor cells circulating in the blood might be possible ... branched synthetic polymers, which could efficiently sift and capture ... University of Illinois at Chicago. Dendrimers have been ... delivery vehicle, but in the new study they were ...
    Cached Medicine News:Health News:MU researchers develop tool that saves time, eliminates mistakes in diabetes care 2Health News:Not Everyone Shuns Fruits and Veggies 2Health News:Presenteeism: A new word for working when sick 2Health News:NJ docs beat fed deadline: Signing up in droves for electronic health records 2Health News:C-Section Rate Drops for First Time in a Decade in U.S. 2Health News:C-Section Rate Drops for First Time in a Decade in U.S. 3Health News:Molecules on branched-polymer surfaces can capture rare tumor cells in blood 2
    ... Compact desktop analyzer for fast point-of-care ... syndrome, deep vein thrombosis and/or pulmonary embolism. ... rooms. , ,When every minute counts, ... determination of troponin T, myoglobin, and D-Dimer ...
    ... Collection Tubes are 100% plastic capillary blood ... of applications, the Capillary Collection Tubes are ... and a micro tube.,The capillary tube uses ... the micro tube thereby eliminating the tendency ...
    ... Scientifics SAFE-T-FILL Capillary Blood Collection Tubes are ... for a wide range of applications, the ... capillary tube, attached cap and a micro ... draw the blood into the micro tube ...
    ... SAFE-T-FILL Capillary Blood Collection Tubes are 100% ... a wide range of applications, the Capillary ... tube, attached cap and a micro tube.,The ... the blood into the micro tube thereby ...
    Medicine Products: